ACCOUNTS - Final Accounts



	BRE-BMR CITP Development Services Limited













	Financial statements

	For the year ended 31 December 2024

	Registered number: 13292471


BRE-BMR CITP Development Services Limited - Registered number: 13292471

Statement of financial position

As at 31 December 2024

		2024		2023
Note		£		£


Current assets
Debtors	4	5,007,143		5,004,048
		5,007,143		5,004,048
Creditors: amounts falling due within one year	5	(78,267)		(67,465)
Net current assets			4,928,876		4,936,583
Total assets less current liabilities			4,928,876		4,936,583

Net assets			4,928,876		4,936,583

Capital and reserves
Called up share capital	1	1
Capital contribution reserve	948,850	948,850
Profit and loss account	3,980,025	3,987,732
	4,928,876	4,936,583

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

Orestis Tzortzoglou

Director

Date: 22 September 2025

The notes on pages 2 to 4 form part of these financial statements.

Page 1


BRE-BMR CITP Development Services Limited

Notes to the financial statements

For the year ended 31 December 2024

1.	General information

BRE-BMR CITP Development Services Limited is a private company limited by shares and incorporated in England and Wales. The registered office of the company is C/O Buzzacott LLP, 130 Wood Street, London, EC2V 6DL and the
principal place of business is The McClintock Building, Granta Park, Great Abington, Cambridge, CB21 6GP. The registered number is 13292471.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Going concern

The directors have received assurance from BRE-BMR CITP Holdco Limited that it will provide continuing financial support to the company sufficient to allow it to continue trading for the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.
However, should this support be withdrawn or future funding not be available, the going concern basis used
in preparing the company's financial statements may be invalid and adjustments would have to be made to
reduce the value of the assets to their realisable amount and to provide for any further liabilities that might
arise. The financial statements do not include any adjustment to the company's assets or liabilities that might
be necessary should the going concern basis not continue to be appropriate

2.3

Debtors

Short-term debtors are measured at transaction price, less any impairment.

2.4

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 2


BRE-BMR CITP Development Services Limited

Notes to the financial statements

For the year ended 31 December 2024

2.Accounting policies (continued)

2.5

Foreign currency translation

Functional and presentation currency

The company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Income statement within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates income.

Employees

The average monthly number of employees during the year was 0 (2023 - 0).
The directors are not considered to be employees of the company as they are remunerated through another group
company.

Debtors

					2024	2023
					£	£


Amounts owed by group undertakings	5,006,941	5,002,996
Other debtors	202	1,052
	5,007,143	5,004,048

Page 3


BRE-BMR CITP Development Services Limited

Notes to the financial statements

For the year ended 31 December 2024

5.	Creditors: amounts falling due within one year
		2024	2023
		£	£

Amounts owed to group undertakings	75,042	27,913
Accruals and deferred income	3,225	39,552
	78,267	67,465

6.	Inclusion in consolidated financial statements

BioMed Realty, L.P. is the parent company of the smallest group of which the company is a member
and for which group financial statements are prepared. The registered office of BioMed Realty, L.P. is
7 St. Paul Street, Suite 820, Baltimore MD, 21202, United States of America.

7.	Auditor's information

The auditor's report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 24 September 2025 by Thomas Allison (Senior statutory auditor) on behalf of Buzzacott Audit LLP.

Page 4